期刊文献+

NSCLC中lincRNA-EPS的表达及其临床意义

Expression and clinical significance of lincRNA-EPS in NSCLC
在线阅读 下载PDF
导出
摘要 目的探索长链非编码RNA(long intergenic non-coding RNA,lincRNA)-EPS在非小细胞肺癌(nonsmall-cell lung cancer,NSCLC)组织中的表达及与临床病理特征的关系。方法采用原位杂交的方法检测lincRNAEPS在NSCLC组织和癌旁组织中表达定位。定量PCR方法检测lincRNA-EPS在NSCLC组织和癌旁组织中的表达水平,分析其与NSCLC临床病理特征的关系。结果 LincRNA-EPS在NSCLC组织中高表达率为71.4%,高于癌旁组织(P<0.01)。LincRNA-EPS在TNMⅢ/Ⅳ期和有淋巴结转移的NSCLC组织中的表达水平高于Ⅰ/Ⅱ期和无淋巴结转移的组织(均P<0.05)。在中低分化与高分化的NSCLC组织中lincRNA-EPS表达比较差异无统计学意义(P>0.05)。结论 NSCLC中lincRNA-EPS的表达与临床分期和淋巴结转移有关。 Objective To investigate the expression of long chain non-coding RNA-EPS( lincRNA-EPS) in nonsmall-cell lung cancer( NSCLC) and to explore its relationship with the clinicopathological characteristics of the disease.Methods To examine the expression and localization of lincRNA-EPS in NSCLC tissues and adjacent normal lung tissues by in-situ hybridization. The expression level of lincRNA-EPS in NSCLC and adjacent normal tissues was tested by quantitative polymerase chain reaction. The association between lincRNA-EPS expression and the clinicopathological characteristics of NSCLC was further analyzed. Results The high expression rate of lincRNA-EPS in NSCLC tissues was 71. 4%,which was significantly higher than that in adjacent normal lung tissues( P〈0. 01). Moreover,lincRNA-EPS level was significantly higher in NSCLC tissues of TNM Ⅲ/Ⅳ stages or with lymph node metastasis,than in NSCLC tissues of TNM Ⅰ/Ⅱ stages or without lymph node metastasis( both P〈0. 05). Nevertheless,the expression of lincRNA-EPS was comparable between NSCLC tissues of low-medium differentiation and those of high-differentiation( P〉0. 05). Conclusion The expression of lincRNA-EPS is related with the clinical stages and lymph node metastasis of NSCLC.
作者 张云嵩 蔡迎玖 张彦伟 董建林 白芳 高小俊 陈田子 Zhang Yunsong Cai Yingjiu Zhang Yanwei(Department of Thoracic Surgery,Tianjin University of Traditional Chinese Medicine Affiliated Wuqing Traditional Chinese Medicine Hospital, Tianjin 301700, China)
出处 《实用肿瘤杂志》 CAS 2017年第4期349-351,共3页 Journal of Practical Oncology
关键词 肺肿瘤 lincRNA-EPS 病理学 lung neoplams lincRNA-EPS pathology
  • 相关文献

参考文献3

二级参考文献11

  • 1yerokun BA,Yang CFJ, Gulack BC,et al. A population - basedanalysis of surgical resection versus stereotactic body radiation therapy for stage I non-small cell lung cancer [ C ]. Beverly : American Association for Thoracic Surger- y,2016.
  • 2Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non- small-cell lung cancer: a pooled analysis of two random- ised trials [J].Lancet Oncol, 2015, 15 ( 3 ) : 70168 - 70173.
  • 3Eisenhauer E,Therasse P, Bogaerts J, et al. New response evaluation criteria in solid turnouts: revised RECIST guideline( version 1. 1 ) [ J ]. Eur J Cancer, 2009,45 : 228 - 247.
  • 4Paz-Ares LG, de Marinis F, Dediu M, et al. PARA- MOUNT: Final overall survival results of the phase m study of maintenance pemetrexed versus placebo immedi- ately after induction treatment with pemetrexed plus cispl- atin for advanced nonsquamous non-small-cell lung cancer [J]. J Clin Oncol,2013,31(23):2895 -2902.
  • 5Barlesi F, Scherpereel A, Gorbunova V, et al. Mainte- nance bevacizumab-pemetrexed after first-line cisplatin- pemetrexed-bevacizumab for advanced nonsquamous nons- mall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase 111 trial [ J ]. Ann Onco1,2014 ,25 ( 5 ) : 1044 - 1052.
  • 6Takeda M, Yamanaka T, Seto T, et al. Bevacizumab be- yond disease progression after first-line treatment with be- vacizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer (West Japan Oncology Group 5910L) : An open-label, randomized, phase 2 trial [ J ]. Cancer, 2016,122 ( 7 ) : 1050 - 9105.
  • 7Thress KS, Paweletz CP, Felip E, et al. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non- small cell lung cancer harboring EGFR T790M [ J ]. Nat Med,2015,21 (6) :560 - 562.
  • 8钟文昭,董嵩,李磊,费世江,杨学宁.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会肺腺癌的国际多学科分类[J].循证医学,2011,11(4):193-225. 被引量:752
  • 9支修益,石远凯,于金明.中国原发性肺癌诊疗规范(2015年版)[J].中华肿瘤杂志,2015,37(1):67-78. 被引量:1333
  • 10吴一龙.非小细胞肺癌血液EGFR基因突变检测中国专家共识[J].中华医学杂志,2015,95(46):3721-3726. 被引量:67

共引文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部